Skeletons in cave reveal Mediterranean secrets
Genetic and chemical analyses of human skeletal remains reveal origins and food habits of first Sicilians
2012-11-29
(Press-News.org) Skeletal remains in an island cave in Favignana, Italy, reveal that modern humans first settled in Sicily around the time of the last ice age and despite living on Mediterranean islands, ate little seafood. The research is published November 28 in the open access journal PLOS ONE by Marcello Mannino and colleagues from the Max Planck Institute for Evolutionary Anthropology, Germany.
Genetic analysis of the bones discovered in caves on the Egadi islands provides some of the first mitochondrial DNA data available for early humans from the Mediterranean region, a crucial piece of evidence in ancestry analysis. This analysis reveals the time when modern humans reached these islands. Mannino says, "The definitive peopling of Sicily by modern humans only occurred at the peak of the last ice age, around 19,000 -26,500 years ago, when sea levels were low enough to expose a land bridge between the island and the Italian peninsula".
The authors also analyzed the chemical composition of the human remains and found that these early settlers retained their hunter-gatherer lifestyles, relying on terrestrial animals rather than marine sources for meat. According to the study, despite living on islands during a time when sea level rise was rapid enough to change within a single human lifetime, these early settlers appear to have made little use of the marine resources available to them. The authors conclude, "These findings have crucial implications for studies of the role of seafood in the diet of Mediterranean hunter-gatherers."
INFORMATION:
Citation: Mannino MA, Catalano G, Talamo S, Mannino G, Di Salvo R, et al. (2012) Origin and Diet of the Prehistoric Hunter-Gatherers on the Mediterranean Island of Favignana (E`gadi Islands, Sicily). PLoS ONE 7(11): e49802. doi:10.1371/journal.pone.0049802
Financial Disclosure: This research was supported by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme, grant number PIEF-GA-2008-219965, awarded to MAM. Funding was also provided by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interest Statement: Carles Lalueza-Fox and David Caramelli are PLOS ONE Editorial Board members. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
PLEASE LINK TO THE SCIENTIFIC ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL goes live after the embargo ends): http://dx.plos.org/10.1371/journal.pone.0049802
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-11-29
Scientists have discovered a cognitive biomarker – a biological indicator of a disease – for young adolescents who are at high risk of developing depression and anxiety. Their findings were published today, 28 November, in the journal PLOS ONE.
The test for the unique cognitive biomarker, which can be done on a computer, could be used as an inexpensive tool to screen adolescents for common emotional mental illnesses. As the cognitive biomarker may appear prior to the symptoms of depression and anxiety, early intervention (which has proven to be one of the most effective ...
2012-11-29
LA JOLLA, CA – Scientists at The Scripps Research Institute (TSRI) have invented a set of chemical tools that is radically simplifying the creation of potential new drug compounds.
Pharmaceutical chemists frequently seek to generate dozens or even hundreds of variations of a given compound to see which works best. The new toolkit—described in the November 28, 2012 issue of the journal Nature—makes this process easier and cheaper, enabling previously time- and cost-prohibitive chemical modifications. This fundamental innovation is already being adopted by drug companies ...
2012-11-29
Judgments we make with a moral underpinning are made more quickly and are more extreme than those same judgments based on practical considerations, a new set of studies finds. However, the findings, which appear in the journal PLOS ONE, also show that judgments based on morality can be readily shifted and made with other considerations in mind.
"Little work has been done on how attaching morality to a particular judgment or decision may affect that outcome," explains Jay Van Bavel, an assistant professor in New York University's Department of Psychology and one of the ...
2012-11-29
Researchers report that screening for KRAS and BRAF mutations can reduce the cost of anti-EGFR treatment for metastatic colorectal cancer but with a very small reduction in overall survival according to a new study published on November 28 in the Journal of the National Cancer Institute.
Metastatic colorectal cancer patients whose tumors harbor mutations in KRAS (and to a lesser extent, in BRAF) are unlikely to respond to costly anti-EGFR therapies. Screening of patients who are candidates for these therapies for mutations in one of these genes (KRAS) has been recommended, ...
2012-11-29
Researchers found that aspirin use is associated with a decreased risk of developing hepatocellular carcinoma and death from chronic liver disease (CLD), according to a study published November 28 in the Journal of the National Cancer Institute.
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, occurs mainly among patients with CLD. Previous reports have linked chronic inflammation due to CLD to cellular processes that could promote carcinogenesis. Because of their anti-inflammatory properties and widespread use to prevent cardiovascular and ...
2012-11-29
The combined loss of two tumor suppressor genes, retinoblastoma (RB) and phosphatase and tensin homolog (PTEN) was shown to be strongly associated with progression of DCIS to invasive breast cancer, according to a study published November 28 in the Journal of the National Cancer Institute.
Ductal carcinoma in situ (DCIS) is a breast cancer precursor lesion for which there are no established markers defining risk of progression to invasive breast cancer. As a result, the majority of women are treated uniformly with surgery and radiation therapy potentially with additional ...
2012-11-29
HOUSTON – (Nov. 29, 2012) – Prostate cancer presents a dilemma for patients and the physicians who treat them. Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and which need aggressive treatment?
Drs. Ming-Jer and Sophia Tsai, both professors in the department of molecular and cellular biology at Baylor College of Medicine, think a receptor called COUP-TFII that they have long studied may point the way to an answer. In a study that appears online in the journal Nature, they show that high levels (overexpression) ...
2012-11-29
HOUSTON -- (Nov. 29, 2012) – Nearly three-quarters of mutations in genes that code for proteins – the workhorses of the cell – occurred within the past 5,000 to 10,000 years, fairly recently in evolutionary terms, said a national consortium of genomic and genetic experts, including those at Baylor College of Medicine.
"One of the most interesting points is that Europeans have more new deleterious (potentially disease-causing) mutations than Africans," said Dr. Suzanne Leal, professor of molecular and human genetics at BCM and an author of the report. She is also director ...
2012-11-29
Intent on developing wheat varieties with higher yields and enhanced nutritional content, researchers at the University of California, Davis, have teamed up with scientists at nine other institutions in an attempt to sequence the wheat genome.
Results from that endeavor, led by researchers at the U.K.-based Biotechnology and Biological Sciences Research Council, will be reported Nov. 29 in the journal Nature.
"This work moves us one step closer to a comprehensive and highly detailed genome sequence for bread wheat, which along with rice and maize is one of the three ...
2012-11-29
A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health.
The combination of protease inhibitors lopinavir and ritonavir contributed to an overall reduction of 40 percent in the rate of malaria among a group of HIV-positive infants and children up to 6 years old in Uganda who were also being treated with anti-malarial drugs. This reduction was in comparison to malaria incidence among children receiving a drug treatment ...
LAST 30 PRESS RELEASES:
[Press-News.org] Skeletons in cave reveal Mediterranean secrets
Genetic and chemical analyses of human skeletal remains reveal origins and food habits of first Sicilians
